Actusnews Wire

The newsfeed available here is provided by our content partner ActusNews. It is a major and wide-reaching newswire & news provider that provides information, press releases and multimedia content for media, journalists and the general public. ActusNews enjoys a high reputation and great popularity, especially among listed companies in its home market of France.

The NewsWire Hub ("X-Billboard") currently comprises six of the most important international news sources and is supplemented by a stock market information service and additional RNS News. The individual newswire services complement each other and form a complementary information offering that covers more than three quarters of the official news sources on which editorial offices worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
System-State: Number of processed items 1.159 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              

Actusnews Wire is an important, trusted and reliable news source for private investors, investors and traders, which can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. Those who want to take a closer look at the news can access the respective news item and other analysis tools directly via the detailed views of the info cards.

NEWS
EXPLORER
FR0011051598
State: 31.03.2025 | 12AM
Do you already know our new terminal view? Click here.
FIGI: BBG009H7XGP7
ALMIB

Amoeba SA
GICS: - · Sector: EQTY · Sub-Sector: -
NAME
Amoeba SA
ISIN
FR0011051598
TICKER
ALMIB
MIC
XPAR
REUTERS
ALMIB.PA
BLOOMBERG
ALMIB FP
Thu, 27.03.2025       Amoeba

Communiqué de presse    Deux avancées décisives en 2024 dans l'activité biocontrôle : la signature d'un protocole d'accord avec Koppert, leader mondial du biocontrôle, ainsi que la réception des conclusions positives et définitives de l'EFSA sur sa substance acti...
Thu, 27.03.2025       Amoeba

Press release   Two decisive milestones in 2024 in the field of biocontrol : the signing of a Memorandum of Understanding (MoU) with Koppert, world leader in biocontrol, and the receipt of the EFSA's positive and definitive conclusions on its biocontrol active substance; Major advances in the field of cosmetics with the excellent ...
Thu, 20.03.2025       Amoeba

Press release Chassieu (France), 20 March 2025 - 6pm - Amoéba (FR0011051598 - ALMIB), an industrial greentech specialized in the development of natural microbiological solutions based on the patented use of amoebae, announces its participation for the 2nd consecutive year in the European SAGROPIA project, which aims to advance crop protectio...
Thu, 20.03.2025       Amoeba

Communiqué de presse   Chassieu (France), le 20 mars 2025 - 18h - Amoéba (FR0011051598 - ALMIB), greentech industrielle spécialisée dans le développement de solutions microbiologiques naturelles basées sur l'exploitation brevetée d'amibes, annonce sa participation pour la 2ème ann...
Thu, 13.03.2025       Amoeba

Communiqué de presse Chassieu (France), le 13 mars 2025, - 14h - Amoéba (FR0011051598 - ALMIB ), greentech industrielle spécialisée dans le développement de solutions microbiologiques naturelles basées sur l'exploitation brevetée d'amibes, a le plaisir d'annoncer sa participati...
Mon, 10.03.2025       Amoeba

Communiqué de presse Chassieu (France), le 10 mars 2025, – 18h - Amoéba (FR0011051598 - ALMIB ), greentech industrielle spécialisée dans le développement de solutions microbiologiques naturelles basées sur l'exploitation brevetée d'amibes, annonce l'extension des cap...
Mon, 10.03.2025       Amoeba

Press release Chassieu (France), 10 March 2025 - 6 pm - Amoéba (FR0011051598 - ALMIB ), an industrial greentech specialising in the development of natural microbiological solutions based on the patented use of amoebae, announces the extension of production capacity at its Chassieu site (Greater Lyon, France), in line with its...
Thu, 23.01.2025       Amoeba

Press release Chassieu (France), 23 January 2025 – 6.00 pm - Amoéba (FR0011051598 - ALMIB), an industrial greentech specialising in the development of natural microbiological solutions based on the patented use of amoebae, announces that Euroland Corporate has initiated the coverage of its stock. Euroland Corporate has begun monitoring...
Thu, 23.01.2025       Amoeba

Communiqué de presse Chassieu (France), le 23 janvier 2024 – 18h00 - Amoéba (FR0011051598 - ALMIB ), greentech industrielle spécialisée dans le développement de solutions microbiologiques naturelles basées sur l'exploitation brevetée d'amibes, annonce l'initiation de la couverture d...
Wed, 15.01.2025       Amoeba

Press release   Chassieu (France), 15 January 2025 – 5.45 pm - Amoéba (FR0011051598 - ALMIB), an industrial greentech specialising in the development of natural microbiological solutions based on the patented use of amoebae, announces that the European Food Safety Authority (EFSA) has published the final assessment report on Amo&e...
Wed, 15.01.2025       Amoeba

Communiqué de presse   Chassieu (France), le 15 janvier 2025 – 17h45 - Amoéba (FR0011051598 - ALMIB), greentech industrielle spécialisée dans le développement de solutions microbiologiques naturelles, annonce que l'Autorité européenne de sécurité des aliments (EFSA) a pub...
Tue, 17.12.2024       Amoeba

Communiqué de presse   Chassieu (France), le 17 décembre 2024 – 8h30 - Amoéba (FR0011051598 - ALMIB), greentech industrielle spécialisée dans le développement de solutions microbiologiques naturelles basées sur l'exploitation brevetée d'amibes, rappelle l'organisation d&...
Mon, 16.12.2024       Amoeba

Press release Receipt of the final conclusions validating the efficacy and low-risk profile of Amoéba's biocontrol active substance; This validation, coupled with the Memorandum of Understanding signed with Koppert, world leader in biocontrol, paves the way for the upcoming launch of AXPERA, the new innovative biofungicide solution de...
Mon, 16.12.2024       Amoeba

Communiqué de presse   Réception des conclusions définitives qui valident l'efficacité et le profil à faible risque de la substance active de biocontrôle d'Amoéba ; Cette validation, couplée au protocole d'accord signé avec Koppert, leader mondial du biocontr&oci...

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.


On behalf of the international investor community, we would like to thank AccessWire for providing the news and data feeds